AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 PfenexTELIX PharmaceuticalStarpharmaProMetic Life SciencesParadigm Biopharmaceuticals
SymbolNYSEAMERICAN:PFNXASX:TLXASX:SPLTSE:PLIASX:PAR
Price Information
Current Price$8.11A$1.47A$1.00N/AA$2.41
52 Week RangeBuyN/AN/AHoldN/A
Beat the Market™ Rank
Overall Score1.20.50.50.60.6
Analysis Score3.50.00.00.00.0
Community Score2.42.72.32.63.0
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.00.00.60.0
Analyst Ratings
Consensus RecommendationBuyN/AN/AHoldN/A
Consensus Price Target$15.50N/AN/AN/AN/A
% Upside from Price Target91.12% upsideN/AN/AN/AN/A
Trade Information
Market Cap$185.13 million$372.56 million$372.54 millionC$315.66 million$476.73 million
BetaN/AN/AN/AN/AN/A
Average Volume341,475N/A544,8248,002N/A
Sales & Book Value
Annual RevenueN/A$3.49 million$7.73 millionC$39.91 million$3.78 million
Price / SalesN/A106.9148.190.00126.06
CashflowN/AA$0.18 per shareA$0.10 per shareN/AA$0.37 per share
Price / CashN/A8.3510.423.946.44
Book ValueN/AA$0.28 per shareA$0.10 per shareC$6.07 per shareA$0.40 per share
Price / BookN/A5.319.800.005.98
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AA($0.12)A($0.04)C($63.06)A($0.10)
Trailing P/E Ratio0.00N/AN/AN/AN/A
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A3.04%4.92%37.47%1.17%
Current RatioN/A5.52%6.05%4.06%66.64%
Quick RatioN/A5.42%6.01%3.66%66.37%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees71N/AN/A487N/A
Shares Outstanding34.22 million253.44 million372.54 million23.31 million197.81 million
Next Earnings Date8/13/2020 (Estimated)N/AN/AN/AN/A
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.